In a significant development for the Indian healthcare sector, the cardiac and anti-diabetes drugs market has expanded more than threefold over the past decade,
India’s biotechnology sector has achieved a significant milestone, currently valued at $150 billion. Despite this impressive figure, much of the sector's innovation and product
In a significant development for public health, Union Minister Dr. Jitendra Singh, a nationally recognized diabetologist, today unveiled the findings of the ICMR-India Diabetes
India is on track to potentially account for 8-10% of the global market share in Contract Research, Development, and Manufacturing Organizations (CDMOs) by 2033,
Axis Securities Report Highlights Positive Trends for Q2 FY25
The Indian pharmaceutical industry is poised for a robust year, with revenue growth projected at 8.5%
The World Health Organization (WHO) has announced the prequalification of Cecolin, a new human papillomavirus (HPV) vaccine, for use in a single-dose schedule. This